|

Non-invasive Differentiation of Supraventricular Tachyarrhythmia

RECRUITINGSponsored by RWTH Aachen University
Actively Recruiting
SponsorRWTH Aachen University
Started2021-09-01
Est. completion2024-09-30
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

1. Questionnaire for supraventricular tachycardia: About history and targeted diagnosis of supraventricular tachycardia 2. Extended Signal-averaged ECG for detailed P-Wave analysis and to calculate a virtual atrial electrocardiogram (ECG)

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Scheduled for ablation of a supraventricular tachycardia (atrial fibrillation, typical atrial flutter, AV nodal reentry tachycardia, accessory pathway)
* majority

Exclusion Criteria:

* Unstable patient with need for intensive medical care
* Lack of language skills or limited cognitive abilities that prevent a differentiated anamnesis and information.

Exclusion criteria for study section Questionnaire:

\- Competing clinically present arrhythmias, including relevant supra- and ventricular extrasystole (\>5%/die).

Exclusion criteria for study section Extended high-resolution ECG:

* Previous electrophysiological ablation at the same site for atrial fibrillation.
* Relevant supra- and ventricular extrasystole (\>5%/die).
* Other clinically present arrhythmias are not excluded if they can be sequentially triggered and ablated (e.g. atrial fibrillation and atrial flutter). Since separate detection is possible with the high-resolution ECG.
* Implanted active electrical device (e.g. pacemaker, defibrillator, deep brain pacemaker)
* Allergy to measuring electrodes

Conditions3

Atrial FibrillationHeart DiseaseSupraventricular Arrhythmia

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.